메뉴 건너뛰기




Volumn 49, Issue 4, 1999, Pages 89-92

The effects of glibenclamide on serum lipids and lipoproteins in type II non-insulin dependent diabetes mellitus

Author keywords

[No Author keywords available]

Indexed keywords

GLIBENCLAMIDE; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

EID: 0032744206     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (7)

References (19)
  • 1
    • 0030812762 scopus 로고    scopus 로고
    • Insulin and sulfonylurea therapy in NIDDM patients. Are the effects on lipoprotein metabolism diferent even similar blood glucose control?
    • Romano G, Patti L, Innelli F, et al. Insulin and sulfonylurea therapy in NIDDM patients. Are the effects on lipoprotein metabolism diferent even similar blood glucose control? Diabetes, 1997;46:1601-6.
    • (1997) Diabetes , vol.46 , pp. 1601-1606
    • Romano, G.1    Patti, L.2    Innelli, F.3
  • 2
    • 0029887385 scopus 로고    scopus 로고
    • LDL from patients with well-controlled IDDM is not more susceptible to in vitro oxidation
    • Jenkin AJ, Klein RL, Chassereau CN, et al. LDL from patients with well-controlled IDDM is not more susceptible to in vitro oxidation. Diabetes, 1996;45:662-67.
    • (1996) Diabetes , vol.45 , pp. 662-667
    • Jenkin, A.J.1    Klein, R.L.2    Chassereau, C.N.3
  • 3
    • 0025057564 scopus 로고
    • Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients
    • Wu MS, Johnston P, Shen WH, et al. Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients. Diabetes Care, 1990;13:1-8.
    • (1990) Diabetes Care , vol.13 , pp. 1-8
    • Wu, M.S.1    Johnston, P.2    Shen, W.H.3
  • 4
    • 0023220416 scopus 로고
    • Lipoprotein metabolism in diabetes mellitus
    • Howard BV. Lipoprotein metabolism in diabetes mellitus. J. Lipid. Res. 1987;28:613-28.
    • (1987) J. Lipid. Res. , vol.28 , pp. 613-628
    • Howard, B.V.1
  • 5
    • 13044296328 scopus 로고    scopus 로고
    • Perspective in diabetes. Thiazolidinediones in the treatment of insulin resistance and type II diabetes
    • Saltiel AR, Olefsky JM. Perspective in diabetes. Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes, 1996;45:1666-69.
    • (1996) Diabetes , vol.45 , pp. 1666-1669
    • Saltiel, A.R.1    Olefsky, J.M.2
  • 6
    • 0031737669 scopus 로고    scopus 로고
    • In vivo evidence for increased apolipoprotein A-I catabolism in subejcts with impaired glucose tolerance
    • Pietzsch J, Julin U, Henefeld M. In vivo evidence for increased apolipoprotein A-I catabolism in subejcts with impaired glucose tolerance. Diabetes , 1998;47:1928-34.
    • (1998) Diabetes , vol.47 , pp. 1928-1934
    • Pietzsch, J.1    Julin, U.2    Henefeld, M.3
  • 7
    • 0031677781 scopus 로고    scopus 로고
    • Tissue specificity of sulfonylureas. Studies on cloned cardiac and B-cell K ATP channels
    • Gribble FM, Tucker SJ, Seino S, et al. Tissue specificity of sulfonylureas. Studies on cloned cardiac and B-cell K ATP channels. Diabetes, 1998;47:1412-18.
    • (1998) Diabetes , vol.47 , pp. 1412-1418
    • Gribble, F.M.1    Tucker, S.J.2    Seino, S.3
  • 8
    • 0003512785 scopus 로고
    • Diabetes mellitus: Report of a WHO study group
    • Geneva, World Health Organization
    • World Health Organization. Diabetes mellitus: Report of a WHO study group. Geneva, World Health Organization, 1985, (Tech. Report series. 727).
    • (1985) Tech. Report Series 727
  • 9
    • 0015348189 scopus 로고
    • Estimation of the concentration of low-density lipoprotcin cholesterol in plasma without use of preparative ultra cnetrifuge
    • Friedwald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotcin cholesterol in plasma without use of preparative ultra cnetrifuge. Clin. Chem., 1972;18:490-502.
    • (1972) Clin. Chem. , vol.18 , pp. 490-502
    • Friedwald, W.T.1    Levy, R.I.2    Fredrickson, D.S.3
  • 10
    • 84944283389 scopus 로고
    • A comparison of methods for the estimation of plasma low and very low-density lipoprotein cholesterol
    • DeLong DM, DeLong ER, Wood PD, et al. A comparison of methods for the estimation of plasma low and very low-density lipoprotein cholesterol. JAMA., 1986;256:2372-77.
    • (1986) JAMA. , vol.256 , pp. 2372-2377
    • DeLong, D.M.1    Delong, E.R.2    Wood, P.D.3
  • 11
    • 0029949418 scopus 로고    scopus 로고
    • Hypertriglyceridemia and low cholesterol in Japanese patients with NIDDM
    • Okubo M, Murase T. Hypertriglyceridemia and low cholesterol in Japanese patients with NIDDM. Diabetes, 1996;46(Suppl 3):23-25.
    • (1996) Diabetes , vol.46 , Issue.3 SUPPL. , pp. 23-25
    • Okubo, M.1    Murase, T.2
  • 12
    • 0018095625 scopus 로고
    • Severity of coronary atherosclerosis related to lipoprotein concentration
    • Jenkins PJ, Harper RW, Nestel PJ. Severity of coronary atherosclerosis related to lipoprotein concentration. Dr. Med. J., 1978;II:388-90.
    • (1978) Dr. Med. J. , vol.2 , pp. 388-390
    • Jenkins, P.J.1    Harper, R.W.2    Nestel, P.J.3
  • 13
    • 0030952963 scopus 로고    scopus 로고
    • High-density lipoprotein apolipoprotein A1 kinetics in NIDDM: A stable isotope study
    • Frenais R, Ouguerram K, Maugeais C, et al. High-density lipoprotein apolipoprotein A1 kinetics in NIDDM: A stable isotope study. Diabetologia, 1997;40:578-83.
    • (1997) Diabetologia , vol.40 , pp. 578-583
    • Frenais, R.1    Ouguerram, K.2    Maugeais, C.3
  • 14
    • 84948722091 scopus 로고
    • Lipid metabolism in noninsulin-dependent diabetes mellitus
    • Greenfield MS, Doberne L, Rosnethal M, et al. Lipid metabolism in noninsulin-dependent diabetes mellitus. Arch. Intern. Med., 1982;142:1498-1500.
    • (1982) Arch. Intern. Med. , vol.142 , pp. 1498-1500
    • Greenfield, M.S.1    Doberne, L.2    Rosnethal, M.3
  • 15
    • 0020951544 scopus 로고
    • The effect of long-term glibenclamide treatment on glucose tolerance, insulin secretion and serum lipids in subjects with impaired glucose tolerance
    • Ratzmann KP, Wirt S, Schulz B. The effect of long-term glibenclamide treatment on glucose tolerance, insulin secretion and serum lipids in subjects with impaired glucose tolerance. Diabetes Metab., 1983;9:87-93.
    • (1983) Diabetes Metab. , vol.9 , pp. 87-93
    • Kp, R.1    Wirt, S.2    Schulz, B.3
  • 16
    • 0022364779 scopus 로고
    • Effect of sulfonyurea therapy on plasma lipids and high-density lipoprotein compostion in non-insulin dependent diabetes mellitus
    • Howard BV, Xiaoren P, Harper I, et al. Effect of sulfonyurea therapy on plasma lipids and high-density lipoprotein compostion in non-insulin dependent diabetes mellitus. Am. J. Med., 1985;79(Suppl.3B):78-85.
    • (1985) Am. J. Med. , vol.79 , Issue.SUPPL. 3B , pp. 78-85
    • Howard, B.V.1    Xiaoren, P.2    Harper, I.3
  • 17
    • 0022374884 scopus 로고
    • Combination insulin/Glyburide therapy in type II diabetes mellitus. Effects on lipoprotein metabolism and glucoregulation
    • Falko JM, Osei K. Combination insulin/Glyburide therapy in type II diabetes mellitus. Effects on lipoprotein metabolism and glucoregulation. Am. J. Med., 1985;79(suppl. 2B):92-101.
    • (1985) Am. J. Med. , vol.79 , Issue.SUPPL. 2B , pp. 92-101
    • Falko, J.M.1    Osei, K.2
  • 18
    • 0022348094 scopus 로고
    • Effects of glyburide therapy on lipoproteins in non-insulin dependent diabetes mellitus
    • Hughes TA, Kramer JO, Segrest JP. Effects of glyburide therapy on lipoproteins in non-insulin dependent diabetes mellitus. Am. J. Med. 1985;79(suppl. 3B):86-91.
    • (1985) Am. J. Med. , vol.79 , Issue.SUPPL. 3B , pp. 86-91
    • Hughes, T.A.1    Kramer, J.O.2    Segrest, J.P.3
  • 19
    • 0019774058 scopus 로고
    • The effects of glibenclamide and insulin on plasma high-density lipoprotein in diabetes
    • Tamai T, Nakai T, Yamada S, et al. The effects of glibenclamide and insulin on plasma high-density lipoprotein in diabetes. Artery, (Abstract):1982;9:477-93.
    • (1982) Artery, (Abstract) , vol.9 , pp. 477-493
    • Tamai, T.1    Nakai, T.2    Yamada, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.